Weiss Multi-Strategy Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-30,000	Closed	-$3.45M	–	586
2014 Q4	$3.45M	Sell	30,000 -4,500	-13%	-$545K	0.12%	158
2014 Q3	$5.39M	Buy	34,500 +6,930	+25%	+$1M	0.13%	176
2014 Q2	$3.4M	Buy	27,570 +8,290	+43%	+$916K	0.07%	276
2014 Q1	$2M	Sell	19,280 -3,310	-15%	-$339K	0.04%	354
2013 Q4	$2.03M	Sell	22,590 -21,500	-49%	-$1.71M	0.04%	335
2013 Q3	$2.95M	Buy	44,090 +14,090	+47%	+$971K	0.06%	296
2013 Q2	$1.99M	Buy	+30,000	New	+$1.72M	0.06%	323

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SLXP Position: Q1 2015 in Review

Weiss Multi-Strategy Advisers sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 30,000 shares — an estimated $3.45M sold.

Weiss Multi-Strategy Advisers first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $5.39M in Q3 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Weiss Multi-Strategy Advisers reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 30,000 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $3.45M.
Weiss Multi-Strategy Advisers first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's SALIX PHARMACEUTICALS LTD DEL position peaked at $5.39M in Q3 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.